Companies from Johnson & Johnson to Eli Lilly, Amazon and Nvidia are announcing health-related deals at the JPMorgan Health ...
Despite the hype over artificial intelligence in medicine, the systems require consistent monitoring and staffing to put in ...
AI was intended to save patients cost in health care. However, experts say it's costlier than expected because humans need to ...
A common thread among these themes is the need for courage — courage to implement commonsense and well-known solutions to pressing and longstanding problems; courage to challenge the deeply entrenched ...
The rapidly spreading wildfires that have transformed much of Los Angeles County into a raging hellscape are not only ...
A group of health advocates and Maine lawmakers say Robert F. Kennedy Jr. is “utterly unqualified” to serve as Health ...
The US Occupational Safety and Health Administration terminated rulemaking aimed at slowing the spread of Covid-19 in ...
If Oz is confirmed by the U.S. Senate, he'll immediately lead an agency that provides health care for 160 million Americans ...
John D. Carpten, Ph.D., a prominent genomics researcher and chief scientific officer at cancer research and treatment institution City of Hope, has these concerns.
Carter Worth, founder and CEO of Worth Charting, joins CNBC's 'Power Lunch' to discuss outlooks on health care.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback